Medicaid lost $1 billion in savings to illegal medical cannabis

Cost efficiency is a major concern for any healthcare provider, always searching for a more affordable, effective method of treatment. Medicaid has not been able to cash in the savings after reported having lost out on $1 billion in saving on prescriptions if cannabis were legalized.

A recent article by Forbes examined a recent Health Affairs study. Between 2007 and 2014, Medicare Part D enrollees were able to replace expensive prescription drugs with medical cannabis. The switch from pill to leaf was estimated at an average saving of $19.83 million per state per year.

“Total estimated Medicaid savings associated with these laws ranged from $260.8 million in 2007 to $475.8 million in 2014,” wrote lead authors Ashley C. Bradford and W. David Bradford. “The national savings for fee-for-service Medicaid would have been approximately $1.01 billion.”

Read the full story by clicking the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.